|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-4-5
|
|
pubmed:abstractText |
Intramyocardial injection of bone marrow cells has been proposed as a new therapeutic option for patients with chronic ischemic heart disease. We investigated whether autologous bone marrow-derived mononuclear cell injection into the myocardium of patients with drug-refractory ischemia reduces anginal symptoms, improves left ventricular (LV) function, increases myocardial perfusion, and alters the extent of scar tissue.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
574-80
|
|
pubmed:meshHeading |
pubmed-meshheading:16595489-Aged,
pubmed-meshheading:16595489-Angina Pectoris,
pubmed-meshheading:16595489-Bone Marrow Transplantation,
pubmed-meshheading:16595489-Chronic Disease,
pubmed-meshheading:16595489-Drug Resistance,
pubmed-meshheading:16595489-Fluorodeoxyglucose F18,
pubmed-meshheading:16595489-Humans,
pubmed-meshheading:16595489-Injections,
pubmed-meshheading:16595489-Leukocytes, Mononuclear,
pubmed-meshheading:16595489-Male,
pubmed-meshheading:16595489-Middle Aged,
pubmed-meshheading:16595489-Myocardial Ischemia,
pubmed-meshheading:16595489-Myocardial Reperfusion,
pubmed-meshheading:16595489-Myocardium,
pubmed-meshheading:16595489-Organophosphorus Compounds,
pubmed-meshheading:16595489-Organotechnetium Compounds,
pubmed-meshheading:16595489-Radiopharmaceuticals,
pubmed-meshheading:16595489-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:16595489-Transplantation, Autologous,
pubmed-meshheading:16595489-Ventricular Function, Left
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
|
|
pubmed:affiliation |
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
|
|
pubmed:publicationType |
Journal Article
|
